Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
08/2010
08/11/2010CN101797310A Fat reduction traditional Chinese medicine composite capable of removing dampness and absorbing clot as well as activating blood circulation and dissipating blood stasis
08/11/2010CN101797235A Carbazochrome sodium sulfonate oral disintegrating tablets and preparation method thereof
08/11/2010CN101485447B Ferulaic acid cyclodextrin inclusion compound preparation method
08/11/2010CN101485446B Preparation method of garlic oil cyclodextrin or cyclodextrin derivate inclusion compound
08/11/2010CN101416982B Preparation method of external natural carbonate emergency life-saving hemostat
08/11/2010CN101390877B Preparation method of natural montmorillonite emergency haemostatic for external use
08/11/2010CN101318933B Isoquinolinium compounds with antithrombotic activity, preparation method and application thereof
08/11/2010CN101317869B Method for extracting flavone from capillary wormwood
08/11/2010CN101240030B Conjugate constructed from normal undecyl and RGD peptide, and its synthesis and application in medicine
08/11/2010CN101240029B Conjugate constructed from normal heptyl and RGD peptide, and its synthesis method and application
08/11/2010CN101011409B Collunarium containing vitamin B12
08/11/2010CN101011145B Edible Collybia albuminosa(Berk.) Petch stuffing
08/10/2010US7772001 Determining preferential gene expression pattern in embryonic cells; obtain cells, monitor gene expresion products, incubate with animal growth regulators, monitor gene expresion pattern and differentiation in cells
08/10/2010CA2451605C Diamine derivatives
08/10/2010CA2447021C Pyridyl cyanoguanidine compounds
08/10/2010CA2440714C Pyrazolopyrimidines as therapeutic agents
08/10/2010CA2362864C New gymnemic acid derivatives, their preparation, pharmaceutical composition containing them and their medical use
08/05/2010WO2010088304A1 Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
08/05/2010WO2010087781A1 Polyelectrolyte complexes with bound peptides
08/05/2010WO2010087471A1 Hydroxypyrazinecarboxamide derivatives
08/05/2010WO2010087313A1 Neurite elongation stimulator
08/05/2010WO2010087244A1 Cyclic amino alcohol compound
08/05/2010WO2010086427A1 Pharmaceutical forms for the release of active compounds
08/05/2010WO2010086425A1 Pharmaceutical forms for the release of active compounds
08/05/2010WO2010086185A1 Nampt and vitamin b3 for treating or preventing diseases
08/05/2010WO2010056765A3 Antidotes for factor xa inhibitors and methods of using the same in combination with blood coagulating agents
08/05/2010WO2010055119A3 Pharmaceutical composition comprising pimobendan
08/05/2010WO2003060149A9 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/05/2010US20100198344 Sustained drug-releasing stent
08/05/2010US20100197917 Coumarin derivatives useful as tnf alpha inhibitors
08/05/2010US20100197758 Ischemia/reperfusion protection compositions and methods of using
08/05/2010US20100197716 N-linked heterocyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
08/05/2010US20100197707 Platelet manipulation to reduce the incidence of and treat endovascular disease and its sequelae, to reduce the incidence of and treat arrhythmias and to reduce the incidence of malignancy
08/05/2010US20100197698 5-phenyl-3-pyridazinone derivative
08/05/2010US20100197618 Extract of rehmannia glutinasa libosch for reducing blood sugar, reducing blood fat, treating leukemia, and preparation method uses thereof
08/05/2010US20100197605 Therapeutic use of peptide yglf and combination with kvlpvpq
08/05/2010US20100197600 Use of the peptide his-ser-leu-gly-lys-trp-leu-gly-his-pro-asp-lys-phe alone or in combination with the peptide pro-gly-thr-cys-glu-ile-cys-ala-tyr-ala-ala-cys-thr-gly-cys-oh as a therapeutic agent
08/05/2010US20100197597 Coagulation Factor VII Polypeptides
08/05/2010US20100197566 Method and Apparatus for Preparing an Acellular Red Blood Cell Substitute
08/05/2010US20100197015 Human liver progenitors
08/05/2010US20100196496 Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof
08/05/2010US20100196476 Process for the preparation and pharmaceutical formulations for 4-quinolinones and quinolines and use thereof
08/05/2010US20100196461 Resuscitation fluid
08/05/2010US20100196354 Glutamate receptor antagonists and methods of use
08/05/2010US20100196348 COMBINATION TREATMENT WITH t-PA VARIANT AND LOW MOLECULAR WEIGHT HEPARIN
08/05/2010US20100196337 Methods and compositions for stem cell self-renewal
08/05/2010US20100196329 Composition for treating ischemic limb disease comprising stem cells derived from adipose tissue
08/05/2010US20100196308 Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
08/05/2010CA2750659A1 Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
08/05/2010CA2749698A1 Resuscitation fluid
08/04/2010EP2213743A1 Albumin fusion proteins
08/04/2010EP2213733A2 Factor IX analogues having prolonged in vivo half life
08/04/2010EP2213282A1 Pharmaceutical forms for the release of active compounds
08/04/2010EP2212284A2 Calcium receptor modulating agents
08/04/2010EP2211874A1 Sterilised dialysis solutions containing pyrophosphates
08/04/2010EP1636365B1 Cholesterol biosynthesis pathway modulators and uses thereof
08/04/2010EP1497262B1 Acyl-4-carboxyphenylurea derivatives, method for production and use thereof
08/04/2010EP1343769B1 Benzoylpyridazines
08/04/2010CN1934122B Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
08/04/2010CN101796053A Piperidine derivatives useful as orexin receptor antagonists
08/04/2010CN101796039A Phenylacetic acid compound
08/04/2010CN101795698A Composition for prevention or treatment of disease associated with the production of autoantibody
08/04/2010CN101795682A Intravenous and oral dosing of a direct-acting and reversible P2Y12 inhibitor
08/04/2010CN101795681A Method of preventing nephrocalcinosis
08/04/2010CN101795670A Liquid formulation of G-CSF
08/04/2010CN101792417A Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases
08/04/2010CN101791382A Chinese herbal medicine combination for treating nasal bleeding
08/04/2010CN101791376A Bactericidal haemostatic sticker and preparation method thereof
08/04/2010CN101791375A Chinese compound preparation for prevention and treatment of gynecological hemorrhagic disease
08/04/2010CN101791362A Traditional Chinese medicine preparation for treatment of apoplexy
08/04/2010CN101791332A Compound gingko health product solid preparation
08/04/2010CN101791318A Novel application of bacterial lipopolysaccharides
08/04/2010CN101791309A Oral solid preparation containing clopidogrel hydrogen sulfate
08/04/2010CN101791302A Medicinal composition containing sodium ferulate and preparation method thereof
08/04/2010CN101791290A Tetra-acetylated puerarin self-micro emulsifying medicament delivery system and preparation method thereof
08/04/2010CN101249193B Chinese medicinal composition for curing gynecology hemorrhagic disease
08/04/2010CN101015614B Quality controlling means of Jiuwei hematopoietic oral liquid
08/04/2010CN101006860B Smoke-roasting bamboo salt and its making method
08/03/2010US7767702 Combinations of oxazolidinones such as rivaroxaban with a platelet aggregation inhibitor such as a clopidogrel for the prophylaxis and/or treatment of thromboembolic disorders
08/03/2010US7767701 protein serine/threonine kinase inhibitors such as 2-(2-Chloro-5-fluoro-phenylimino)-5-(2,3-dihydro-benzo[1-6]dioxin-6-ylmethylene)-thiazolidin-4-one, used for treating autoimmune diseases, HIV, cancer, anemia myelodysplastic syndrome and thrombocytopenia
08/03/2010US7767676 2-amino-3,6-dihydro-4-dimethyl-amino-6-ethyl-1,3,5-triazine hydrochloride; advanced glycosylation end-products inhibitor;antidiabetic, insulin resistance, neurodegenerative disorders, renal complications, atherosclerosis, angiopathy
08/03/2010US7767667 Pesticidal heterocycles
08/03/2010US7767415 Removal antigens from blood
08/03/2010US7767207 Interleukin-18 specific immunoglobulins for treatment and prevention of autoimmune, respiratory, reproductive, heart, connective tissue, liver, bone and arthritic disorders
08/03/2010CA2512926C Methods and compositions for inhibition of angiogenesis
08/03/2010CA2409828C Formulation based in heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base
08/03/2010CA2402199C Amidino compounds useful as nitric oxide synthase inhibitors
08/03/2010CA2361949C Heparin, or heparin conjugate, islets of langerhans
07/2010
07/29/2010WO2010084999A1 Immunosuppressive agents and prophylactic and therapeutic agents for autoimmune diseases
07/29/2010WO2010064252A3 Polymer-conjugated albumin hydrogels for controlled release of therapeutic agents
07/29/2010WO2009156724A3 Pyrido-indole-carboxylic acid compounds
07/29/2010US20100191325 Coating containing pegylated hyaluronic acid and a pegylated non-hyaluronic acid polymer
07/29/2010US20100190788 Amide derivatives as kinase inhitors
07/29/2010US20100190783 Triazolone derivatives
07/29/2010US20100190782 Compounds and methods of use
07/29/2010US20100190763 Poly (ADP-Ribose) Polymerase (PARP) Inhibitors
07/29/2010US20100190758 Progesterone Antagonist and Selective Progesterone Modulator in the Treatment of Excessive Uterine Bleeding
07/29/2010US20100190709 Angiogenic composition
07/29/2010US20100189814 Herbomineral formulation for treating sickle cell disease
07/29/2010US20100189773 5-cyano-4- (pyrrolo [2,3] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors
1 ... 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 ... 671